Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conservative Ziconotide Dosing for Neuropathic Pain
NCT03321955Phase 4Completed
- Sponsor
- Albany Medical College
- Start
- Nov 2016
- Primary completion
- Aug 2020
- Modality
- Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of ziconotide in neuropathic pain, sponsored by Albany Medical College. Started Nov 2016; status: completed.
02
Drugs
ziconotide
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT03321955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03321955.